标题 |
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
|
网址 | |
DOI |
10.1016/s2213-2600(20)30154-5
doi
|
其它 |
期刊:The Lancet Respiratory Medicine 作者:Yi‐Long Wu; Ying Cheng; Jianying Zhou; Shun Lü; Yiping Zhang; et al 出版日期:2020-05-29 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |